HIGHLIGHTS
- who: Yoon-Bo Shim et al. from the School of Pharmacy, Sungkyunkwan University, Gyeonggi-do, AstraZeneca, Seoul have published the article: Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data, in the Journal: PLOS ONE of September/17,/2021
- what: Through this study design, the authors were able to measure the pure impact of BM in patients with NSCLC.
- how: To adjust for potential differences the authors used non-cancer-related CCI by summing the scores without cancer-related . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.